We observed that low expression of ZBTB38 correlates with shorter disease-free survival in patients with Gleason 4 + 3 tumours (p < 0.001) while there is no clear correlation in patient with Gleason 3 + 4 tumours (Figure 3d). This evidence concerns the gene ZBTB38 and neoplasm.